B Group Signals Confidence as Retension Pharma Insider Trades Surge, CEO Executes 255K Options in Mid‑Stage Surge of Investor Optimism
Insiders and B Group boost Retension Pharma with new holdings—strong confidence, positive sentiment, and potential upside for long‑term investors.
3 minutes to read